Our Services
Medical Information
Helpful Resources
Published on: 3/18/2026
When an antidepressant isn't working well enough, evidence-based augmentation strategies can help. FDA-approved options include atypical antipsychotics like aripiprazole, brexpiprazole, and quetiapine XR, along with lithium, thyroid hormone T3, bupropion, and, in select cases, stimulants. Adding structured psychotherapy also improves outcomes.
Before adding a medication, confirm the right dose, adequate duration, and adherence, and rule out medical or substance-related contributors. After two adequate medication trials, treatments like TMS, ECT, or esketamine may be appropriate next steps.
Because depression symptoms overlap with many other conditions—thyroid issues, sleep disorders, anxiety, or medication side effects—understanding what's actually driving your symptoms is the critical first step before adjusting treatment. A free, instant, online symptom check can help you clarify what may be going on, identify possible contributors, and give you clear, personalized guidance to bring to your next doctor's visit—so you can make the most informed decision about your next steps.
Reviewed for medical accuracy: 07/09/2026
If you're taking an antidepressant but still feel depressed, you're not alone. Up to one-third of people with major depressive disorder do not fully respond to their first medication. This is often called partial response or treatment-resistant depression.
The good news? Modern psychiatry has clear, evidence-based strategies for what to do next. One of the most effective approaches is learning how to augment antidepressants with other medications—rather than simply stopping or switching right away.
Below, we'll walk through what augmentation means, when it's appropriate, and which strategies are supported by credible clinical guidelines.
Augmentation means adding a second medication to your current antidepressant to boost its effectiveness.
This is different from:
Augmentation is typically considered when:
If you've had no improvement at all, switching medications may be more appropriate.
Before adding another medication, clinicians first confirm:
If you're unsure whether your symptoms align with clinical depression or need help understanding their severity, Ubie's free AI-powered symptom checker takes just 3 minutes and provides personalized insights you can bring directly to your next doctor's appointment.
There are several clinically supported ways to augment antidepressants with other medications. The right option depends on your symptoms, medical history, and side effect tolerance.
Below are the most commonly used strategies.
Certain second-generation (atypical) antipsychotics are FDA-approved specifically to augment antidepressants in major depression.
These include:
Despite the name, these medications are not just for psychosis. At low doses, they can:
These medications require monitoring by a physician.
Lithium is one of the oldest psychiatric medications and remains one of the most evidence-supported augmentation strategies.
Lithium augmentation is often considered when depression is severe or long-standing.
Even in people without thyroid disease, adding liothyronine (T3) can improve antidepressant response.
This strategy is particularly useful in people with subtle thyroid dysfunction or persistent fatigue.
One common strategy for how to augment antidepressants with other medications is combining:
SSRIs target serotonin.
Bupropion affects dopamine and norepinephrine.
This combination can:
This is one of the most common real-world augmentation strategies.
In certain cases—especially when fatigue, low motivation, and poor concentration dominate—clinicians may consider:
These are typically reserved for:
They are not first-line augmentation options but may be appropriate in select cases.
Medication isn't the only way to augment antidepressant treatment.
Adding structured therapy—especially:
has strong evidence for improving outcomes when medication alone isn't enough.
In fact, combining therapy with medication often produces better long-term results than medication alone.
Depression is typically labeled treatment-resistant after:
But this doesn't mean you're out of options.
Other evidence-based treatments include:
These are usually considered after multiple medication attempts.
When learning how to augment antidepressants with other medications, safety is essential.
Adding medications increases:
You should urgently seek medical care if you experience:
Always speak to a doctor before adjusting any medication. Never combine medications without professional guidance.
If you're still depressed despite treatment, it does not mean:
It means your brain may need a more tailored strategy.
Modern depression care is not "one medication and done." It's often a stepwise process that includes:
Persistence matters. So does partnership with a qualified clinician.
If you're unsure whether your current treatment is working:
Coming prepared can make your visit far more productive.
If you're still depressed on medication, there are evidence-based next steps. Augmentation strategies—such as adding an atypical antipsychotic, lithium, thyroid hormone, or bupropion—can significantly improve outcomes when carefully chosen.
Depression can be stubborn. But it is also treatable—even when the first medication doesn't fully work.
If your symptoms are severe, worsening, or include suicidal thoughts, speak to a doctor immediately or seek emergency care. Mental health conditions are medical conditions, and serious symptoms deserve urgent attention.
You are not out of options. You may simply need the right adjustment.
(References)
* Voigt, R., Schneider, H. D., Scheidt, K. M., Reischies, F. M., & Zillich, P. (2022). Augmentation Strategies for Treatment-Resistant Depression: A Systematic Review. *Current Neuropharmacology*, 20(10), 1825–1840.
* Zhu, Y., Zeng, J., Li, Y., Jiang, C., & Xu, Z. (2023). Pharmacological Augmentation Strategies for Treatment-Resistant Depression: A Comprehensive Review. *Journal of Clinical Medicine*, 12(7), 2580.
* D'Andrea, G., & D'Andrea, M. R. (2022). New frontiers in the augmentation of antidepressants. *Expert Review of Clinical Pharmacology*, 15(4), 427–438.
* D'Andrea, G., Bruti, G., Caponnetto, V., Corbo, L., & D'Andrea, M. R. (2023). Ketamine and Esketamine in Treatment-Resistant Depression: A Systematic Review and Meta-Analysis. *Journal of Personalized Medicine*, 13(7), 1038.
* D'Andrea, G., Bruti, G., Corbo, L., Caponnetto, V., & D'Andrea, M. R. (2023). Repurposed drugs as augmentation strategies for treatment-resistant depression: a systematic review. *Expert Opinion on Drug Discovery*, 18(2), 147–158.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.